Show Notes
What is it really like to be an EMA trainee? In the latest episode of Inside EMA, we speak with Maria Iglesias, Martin Botulinski and Andrea Tzoneva about their experiences of EMA's traineeship programme. From regulatory science and innovation to institutional policy, they discuss learning opportunities, mentorship, international collaboration and the diverse career paths that can lead to EMA. The episode highlights how trainees gain hands-on experience, access to training and mentoring, and the opportunity to contribute to work that ultimately helps patients across Europe.
More from Inside EMA
Bees are essential to our ecosystems, food production and biodiversity. But like all animals, they can face health challenges. In the latest episode of Inside EMA, we speak with Miguel Llorens, Scientific Officer in EMA's Veterinary Medicines Division, about the diseases affecting bees, the medicines used to treat them, and how regulators help ensure those medicines are safe, effective and of high quality.
Could medicines one day be developed without animal testing? Scientific innovation is advancing rapidly, and momentum is growing in Europe and globally to reduce andultimately replace the use of animals in research. The EU has launched a roadmap towards phasing out animal testing for chemical safety assessments, and EMA continues to build on its longstanding commitment to the 3Rs principles (replace, reduce, refine animal use). Working with partners across Europe and internationally, EMA is helping drive this transition, supporting the development of alternative approaches that protect both science and patient safety.
Up to 90% of women who are pregnant or breastfeeding use medicines, yet for many of these treatments, reliable safety data remains limited. Why does this gap exist—and how can it be addressed? In this episode of Inside EMA, Corinne de Vries, EMA lead on medicines in pregnancy and breastfeeding, explores the challenges of generating robust safety evidence for these populations. She explains how traditional approaches to clinical research have contributed to the lack of data and why it’s essential to rethink the inclusion of pregnant and breastfeeding individuals in clinical trials. Corinne also shares how regulators and researchers are working to generate better evidence throughout a medicine’s lifecycle. Strengthening this knowledge base is key to empowering mothers and healthcare professionals to make informed, confident decisions about treatment—supporting both maternal health and the wellbeing of their babies.
From clinical trials to real‑world evidence. How is data shaping the future of medicines? Discover how EMA uses data to guide safer, better decisions.
How does EMA help turn innovative ideas into real medicines? In this episode of Inside EMA, we look at how the European Medicines Agency supports developers from early concepts through to patient access. The discussion highlights how regulation and innovation are not opposites, but complementary forces that help deliver safe and effective medicines. Topics include early scientific dialogue, support for SMEs, and EMA’s engagement with innovation ecosystems across Europe. 🎙️ Featuring Emmanuel Cormier, Head of regulatoryscience and innovation, and Alessandro Faia, Communications officer. Learn more: Opportunities to interact with EMA during the development of a medicine